Annual report [Section 13 and 15(d), not S-K Item 405]

Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details)

v3.25.1
Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details) - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 147,707 147,707
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 546,653 1,766,417
Non-vested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 3,018,374 2,191,297
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 240,100 240,100